Global /India /Healthcare /Drug Manufacturers - General /BAFNAPH

Bafna Pharmaceuticals Ltd.

BAFNAPH

• NSE: BAFNAPH • Delayed

134.00INR 1.6%

1.42 USD

As of 20 June 2026, Bafna Pharmaceuticals Ltd. has a market cap of $33.59M USD, ranking #33453 globally and #2237 in India. It ranks #3019 in the Healthcare sector, and #1037 in the Drug Manufacturers - General industry.

Global Rank

33453

Country Rank

2237

Sector Rank

3019

Industry Rank

1037

Key Stats

Market Cap

$33.59MUSD

3.17B INR

Enterprise Value

$36.98MUSD

3.49B INR

Revenue (TTM)

$15.62MUSD

1.47B INR

EBITDA (TTM)

$1.72MUSD

162.09M INR

Net Income (TTM)

$1.02MUSD

96.61M INR

EBITDA Margin

11%

Profit Margin

6.6%

PE Ratio

32.8

PS Ratio

2.2

PB Ratio

3.5

EV/EBITDA

21.5

Company Profile

Country (HQ)

India

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Bansilal Mahaveer Bafna open_in_new

Employees

406

Founded

1981

Website

bafnapharma.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
1.6%	-3.4%	16%	16%	-2.6%	-13%	65%	63%	-0.2%

News

Markets

Exchange	Ticker	Price	Quotes
National Stock Exchange of India (NSE) MIC: XNSE PRIMARY	BAFNAPH Bafna Pharmaceuticals Ltd ISIN: INE878I01022 Shares Out.: Shares Outstanding: 23.656M¹ TV: TradingView: NSE: BAFNAPH SA: Stock Analysis: NSE: BAFNAPH YF: Yahoo Finance: BAFNAPH.NS GF: Google Finance: NSE: BAFNAPH BA: Barron's: BAFNAPH MS: Morningstar: XNSE: BAFNAPH	134.00 INR	TV: TradingView: NSE: BAFNAPH SA: Stock Analysis: NSE: BAFNAPH YF: Yahoo Finance: BAFNAPH.NS GF: Google Finance: NSE: BAFNAPH BA: Barron's: BAFNAPH MS: Morningstar: XNSE: BAFNAPH
Bombay Stock Exchange (BSE / BOM) MIC: XBOM	532989 (BAFNAPH) Bafna Pharmaceuticals Ltd ISIN: INE878I01022 TV: TradingView: BSE: BAFNAPH SA: Stock Analysis: BOM: 532989 YF: Yahoo Finance: 532989.BO GF: Google Finance: BOM: 532989 BA: Barron's: 532989 MS: Morningstar: XBOM: 532989	135.30 INR	TV: TradingView: BSE: BAFNAPH SA: Stock Analysis: BOM: 532989 YF: Yahoo Finance: 532989.BO GF: Google Finance: BOM: 532989 BA: Barron's: 532989 MS: Morningstar: XBOM: 532989

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Bafna Pharmaceuticals Ltd.

Bafna Pharmaceuticals Limited manufactures and sells finished pharmaceutical formulations in India. It also exports its products to Europe, the United Kingdom, Australia, Sri Lanka, Africa, Philippines, Tanzania, Nigeria, and Commonwealth countries. Bafna Pharmaceuticals Limited was founded in 1981 and is based in Chennai, India. Bafna Pharmaceuticals Limited is a subsidiary of SRJR Lifesciences LLP.

Similar Companies

Industry: Drug Manufacturers - General (India)

Name	Market Cap (USD) diff.	PE	Country
Sun Pharmaceutical Industries Ltd. NSE: SUNPHARMA	$45.22B 4.27T INR 135K%	39.1	India
Divi's Laboratories Ltd. NSE: DIVISLAB	$18.38B 1.73T INR 55K%	70.0	India
Torrent Pharmaceuticals Ltd. NSE: TORNTPHARM	$15.17B 1.43T INR 45K%	63.0	India
Dr. Reddy's Laboratories Ltd. NSE: DRREDDY	$11.73B 1.11T INR 35K%	19.6	India
Mankind Pharma Ltd. NSE: MANKIND	$9.87B 931.67B INR 29K%	52.2	India
Zydus Lifesciences Ltd. NSE: ZYDUSLIFE	$9.71B 916.53B INR 29K%	18.6	India

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 2M%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 2M%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 1M%	97.4	United States
Roche Holding AG SIX: RO	$318.3B 256.25B CHF 948K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$284.64B 215.59B GBP 847K%	27.6	United Kingdom
Merck & Co., Inc. NYSE: MRK	$274.03B 816K%	15.1	United States

chevron_leftBack